• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of June 26, 2024

    FDA

    Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System

    BUSINESSWIRE

    Hikma Pharma Generic Dexamethasone Sodium Phosphate Receives Approval in the U.S.

    FDA

    Geneyork`s Generic Dexamethasone Sodium Phosphate Receives Approval in the U.S.

    FDA

    Amneal Expands Injectables Portfolio with 4 New Products

    BUSINESSWIRE

    Enforcement Report - Week of February 2, 2022

    FDA

    Bausch Health`s DEXAVEN Receives New Indication In Poland Patients

    PRNEWSWIRE

    Bausch Health`s DEXAVEN Receives New Indication In Poland

    PRNEWSWIRE

    Aurobindo Pharm`s Generic Dexamethasone Sodium Phosphate Receives Approval In US

    FDA

    Civica Rx & Hikma announce shipments of Heparin & 7 other injectable medicines

    PRESS RELEASE

    TLC announces completion of $27 M financing

    BIOSPECTRUMASIA

    Premier Pharmacy Labs Issues Voluntary Nationwide Recall of all Unexpired Sterile Drug Product Lots Due to Lack of Sterility Assurance

    FDA

    Aurobindo Pharma`s Generic Dexamethasone Sodium Phosphate Receives Approval In US

    FDA

    Somerset Theraps` Generic Dexamethasone Sodium Phosphate Receives Approval in US

    FDA

    Somerset`s Generic Dexamethasone Sodium Phosphate Receives Approval in US

    FDA

    EyeGate’s anti-inflammatory eye drug w/ electric delivery device fail ph 3 trial

    FIERCE BIOTECH

    Amneal Pharms` Generic Dexamethasone Sodium Phosphate Receives Approval in US

    FDA

    Fresenius Kabi USA’s Generic Dexamethasone Sodium Phosphate Receives Approval in the US

    FDA

    Somerset Theraps Generic Dexamethasone Sodium Phosphate Receives Approval In US

    FDA

    Somerset Therap`s Generic Dexamethasone Sodium Phosphate Receives Approval In US

    FDA

    Enforcement Report - Week of February 28, 2018

    FDA

    Enforcement Report - Week of November 29, 2017

    FDA

    Aurobindo gets USFDA nod to manufacture multi disease treatment injection

    ECONOMIC TIMES

    Aurobindo`s Generic Dexamethasone Sodium Phosphate approved in US for Cancer

    FDA

    BD RX`s Generic Dexamethasone Sodium Phosphate approved in US…

    FDA

    Drug shortages become issue in Teva and Mylan hook-up

    FIERCE PHARMA MANUFACTURING

    FDA Drug Shortages: Dexamethasone Sodium Phosphate Injection

    FDA

    FDA Warns vs 20 Unregistered Drugs

    INQUIRER.NET

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.